The Pennant Group, Inc. (PNTG)
NASDAQ: PNTG · Real-Time Price · USD
25.24
+0.76 (3.10%)
Oct 24, 2025, 4:00 PM EDT - Market closed
The Pennant Group Market Cap
The Pennant Group has a market cap or net worth of $872.34 million as of October 27, 2025. Its market cap has decreased by -25.09% in one year.
Market Cap
872.34M
Enterprise Value
1.18B
1-Year Change
-25.09%
Ranking
Category
Stock Price
$25.24
Market Cap Chart
Since October 1, 2019, The Pennant Group's market cap has increased from $422.52M to $872.34M, an increase of 106.46%. That is a compound annual growth rate of 12.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 24, 2025 | 872.34M | -4.23% |
| Dec 31, 2024 | 910.92M | 118.67% |
| Dec 29, 2023 | 416.58M | 27.84% |
| Dec 30, 2022 | 325.85M | -50.42% |
| Dec 31, 2021 | 657.25M | -59.84% |
| Dec 31, 2020 | 1.64B | 77.73% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 1, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 741.04B |
| Johnson & Johnson | 457.77B |
| AbbVie | 402.76B |
| UnitedHealth Group | 328.31B |
| AstraZeneca | 258.55B |
| Novartis AG | 253.40B |
| Novo Nordisk | 236.76B |
| Abbott Laboratories | 220.78B |